Collective Audience (CAUD) S-4/A 9 May 22 Registration of securities issued in business combination transactions (amended) Financial data

Document And Entity Information

Document And Entity Information	9 Months Ended
	Dec. 31, 2021
Document Information Line Items
Entity Registrant Name	ABRI SPAC I, INC.
Document Type	S-4/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Entity Central Index Key	0001854583
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Incorporation, State or Country Code	DE

Balance Sheet

Balance Sheet	Dec. 31, 2021USD ($)
Current assets:
Cash	$ 154,942
Prepaid expenses	321,590
Total current assets	476,532
Cash held in Trust Account	57,340,207
Total assets	57,816,739
Current liabilities:
Accounts payable and accrued expenses	687,531
Warrant liability	170,867
Total current liabilities	858,398
Deferred underwriting commissions	1,500,000
Total liabilities	2,358,398
Commitments and Contingencies (Note5)
Common stock subject to possible redemption, par value $0.0001, 100,000,000 shares authorized; 5,733,920 shares outstanding	52,323,289
Stockholders’ equity:
Preferred stock, par value $0.0001, 1,000,000 shares authorized, none issued and outstanding
Common stock, par value $0.0001, 100,000,000 shares authorized; 1,728,078 shares issued and outstanding	173
Additional paid-in capital	4,262,491
Accumulated deficit	(1,127,612)
Total stockholders’ equity	3,135,052
Total liabilities, redeemable common stock and stockholders’ equity	$ 57,816,739

Balance Sheet (Parentheticals)

Balance Sheet (Parentheticals)	Dec. 31, 2021$ / sharesshares
Statement of Financial Position [Abstract]
Common stock subject to possible redemption, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock subject to possible redemption, shares authorized	100,000,000
Common stock subject to possible redemption, share outstanding	5,733,920
Preferred stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, share issued
Preferred stock, share outstanding
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	1,728,078
Common stock, shares outstanding	1,728,078

Statement of Operations

Statement of Operations	9 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Statement of Comprehensive Income [Abstract]
Operating expenses	$ 1,134,803
Loss from operations	(1,134,803)
Other income:
Interest income	1,299
Change in fair value of warrant liability	5,892
Total other income (expenses)	7,191
Loss before income taxes	(1,127,612)
Benefit from (provision for) income taxes
Net loss	$ (1,127,612)
Weighted-average common shares outstanding, basic and diluted, redeemable shares subject to redemption (in Shares) | shares	2,789,393
Basic and diluted net income per share, redeemable shares subject to redemption (in Dollars per share) | $ / shares	$ (0.05)
Weighted-average common shares outstanding, basic and diluted, non-redeemable shares (in Shares) | shares	1,447,964
Basic and diluted net loss per share, non-redeemable shares (in Dollars per share) | $ / shares	$ (0.68)

Statement of Changes in Stockho

Statement of Changes in Stockholders’ Equity - 9 months ended Dec. 31, 2021 - USD ($)	Common Stock Subject to Possible Redemption	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Mar. 17, 2021
Balance (in Shares) at Mar. 17, 2021
Issuance of common stock to founders for cash		$ 144	24,856		25,000
Issuance of common stock to founders for cash (in Shares)		1,437,500
Sale of 5,733,920 Units, net of underwriting discounts and offering costs	$ 50,589,849
Sale of 5,733,920 Units, net of underwriting discounts and offering costs (in Shares)	5,733,920
Sale of 294,598 Private Units		$ 29	2,945,951		2,945,980
Sale of 294,598 Private Units (in Shares)		294,598
Private Warrant liability			(176,759)		(176,759)
Public Warrant allocation			3,201,884		3,201,884
Accretion of common stock to redemption value	1,733,440		(1,733,440)		(1,733,440)
Forfeiture of founder's shares
Forfeiture of founder's shares (in Shares)		(4,020)
Net loss				(1,127,612)	(1,127,612)
Balance at Dec. 31, 2021	$ 52,323,289	$ 173	$ 4,262,491	$ (1,127,612)	$ 3,135,052
Balance (in Shares) at Dec. 31, 2021	5,733,920	1,728,078

Statement of Changes in Stock_2

Statement of Changes in Stockholders’ Equity (Parentheticals)	9 Months Ended
	Dec. 31, 2021shares
Statement of Stockholders' Equity [Abstract]
Sale of units, net of underwriting discounts and offering costs	5,733,920
Sale of private units	294,598

Statement of Cash Flows

Statement of Cash Flows	9 Months Ended
	Dec. 31, 2021USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,127,612)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liability	(5,892)
Interest earned on marketable securities held in Trust Account	(1,299)
Prepaid expenses	(321,590)
Accounts payable and accrued expenses	687,531
Net cash used in operating activities	(768,862)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment of cash in Trust Account	(57,338,908)
Net cash used in investing activities	(57,338,908)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable - related party	300,000
Repayments of notes payable – related party	(300,000)
Issuance of common stock to founders for cash	25,000
Cash proceeds from sale of Units, net of underwriting discounts paid	55,905,720
Cash proceeds from sale of Private Units	2,945,980
Cash proceeds from issuance of underwriter’s unit purchase option	100
Payment of offering costs	(614,088)
Net cash from financing activities	58,262,712
NET CHANGE IN CASH	154,942
Cash – Beginning of period
Cash – End of period	154,942
Non-cash investing and financing activities:
Issuance of founder shares for related party payables	25,000
Issuance of underwriter’s unit purchase option	360,000
Deferred underwriting fee payable	1,500,000
Common stock subject to redemption	$ 52,323,289

Nature of the Organization and

Nature of the Organization and Business	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
NATURE OF THE ORGANIZATION AND BUSINESS	NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS Abri SPAC I, Inc (“Abri” or the “Company”) was incorporated in the State of Delaware on March 18, 2021. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (our “Initial Business Combination”). The Company has selected December 31 as its fiscal year end. Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to Abri SPAC I, Inc. As of September 30, 2021, and the date of this filing, the Company had not commenced core operations. All activity for the period from March 18, 2021 (inception) through September 30, 2021 relates to the Company’s formation and raising funds through its initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of the Initial Business Combination, at the earliest. The Company will generate non -operating The registration statement pursuant to which the Company registered its securities offered in the Initial Public Offering was declared effective on August 9, 2021. On August 12, 2021, the Company consummated its Initial Public Offering of 5,000,000 units (each, a “Unit” and collectively, the “Units”), at $10.00 per Unit, generating gross proceeds of $50,000,000 and incurring offering costs of $973,988. The Company granted the underwriter a 45 -day -allotments Simultaneously with the consummation of the closing of the Initial Public Offering, the Company completed the private sale of 276,250 units (the “Private Units”) to Abri Ventures I, LLC, the Company’s sponsor (the “Sponsor”) at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $2,762,500. Following the closing of the Initial Public Offering on August 12, 2021, an amount of $50,000,000 net proceeds from the Initial Public Offering and sale of the Private Units was placed in a trust account in the United States maintained by Continental Stock Transfer & Trust Company, as trustee (the “Trust Account”). The funds held in the Trust Account were invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a -7 -Initial On August 19, 2021, the underwriters notified the Company of their intent to exercise of the over -allotment -allotment The stock exchange listing rules provide that the Initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable) at the time of the Company signing a definitive agreement in connection with the Initial Business Combination. The Company will only complete an Initial Business Combination if the post -Initial The payment to the Company’s Sponsor of a monthly fee of $10,000 is for general and administrative services including office space, utilities and secretarial support, which the Company records as operating expense on its statement of operations. However, pursuant to the terms of such agreement, we may delay payment of such monthly fee upon a determination by our audit committee that we lack sufficient funds held outside the trust to pay actual or anticipated expenses in connection with our Initial Business Combination. Any such unpaid amount will accrue without interest and be due and payable no later than the date of the consummation of our Initial Business Combination. This arrangement is being agreed to by its Sponsor for our benefit. We believe that the fee charged by our Sponsor is at least as favorable as we could have obtained from an unaffiliated person. This arrangement will terminate upon completion of our Initial Business Combination or the distribution of the Trust Account to our public stockholders. Other than the $10,000 per month fee, no compensation of any kind (including finder’s fees, consulting fees or other similar compensation) will be paid to our insiders, members of our management team or any of our or their respective affiliates, for services rendered to us prior to or in connection with the consummation of our Initial Business Combination (regardless of the type of transaction that it is). However, such individuals will receive reimbursement for any out -of-pocket The funds outside of the Trust Account are for our working capital requirements in searching for our Initial Business Combination. The allocation such funds represents our best estimate of the intended uses of these funds. If our estimate of the costs of undertaking due diligence and negotiating our Initial Business Combination is less than the actual amount necessary to do so, we may be required to raise additional capital, the amount, availability and cost of which is currently unascertainable. In this event, we could seek such additional capital through loans or additional investments from our insiders, members of our management team or third parties, but our insiders, members of our management team or third parties are not under any obligation to advance funds to, or invest in, us. We will likely use substantially all of the net proceeds of this offering, including the funds held in the Trust Account, in connection with our Initial Business Combination and to pay our expenses relating thereto, including the deferred underwriting commission payable to the underwriter in an amount equal to 3.0% of the total gross proceeds raised in the offering upon consummation of our Initial Business Combination. To the extent that our capital stock is used in whole or in part as consideration to effect our Initial Business Combination, the proceeds held in the Trust Account which are not used to consummate an Initial Business Combination will be disbursed to the combined company and will, along with any other net proceeds not expended, be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways, including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. To the extent we are unable to consummate an Initial Business Combination, we will pay the costs of liquidation from our remaining assets outside of the Trust Account. If such funds are insufficient, our insiders have agreed to pay the funds necessary to complete such liquidation (currently anticipated to be no more than $15,000) and have agreed not to seek repayment of such expenses. We believe that we will not have sufficient available funds to operate for up to the next 12 months (or up to 18 months from the Initial Public Offering if we are required to extend the period of time to consummate an Initial Business Combination), assuming that our Initial Business Combination is not consummated during that time. However, if necessary, in order to meet our working capital needs following the consummation of this offering, our insiders may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our Initial Business Combination, without interest, or, at the lender’s discretion, up to $750,000 of the notes may be converted upon consummation of our Initial Business Combination into additional Private Warrants at a price of $1.00 per warrant. Notwithstanding, there is no guarantee that the Company will receive such funds. Our stockholders have approved the issuance of the Private Warrants upon conversion of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation of our Initial Business Combination. If we do not complete an Initial Business Combination, any loans and advances from our insiders or their affiliates, will be repaid only from amounts remaining outside our Trust Account, if any. The Company’s Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their insider shares and any public shares they may hold in connection with the completion of our Initial Business Combination. In addition, our Sponsor and its officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their insider shares if we fail to complete our Initial Business Combination within the prescribed time frame. However, if its Sponsor or any of its officers, directors or affiliates acquire public shares in or after this offering, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if we fail to complete our Initial Business Combination within the prescribed time frame. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon the completion of the Initial Business Combination either (i) in connection with a stockholder meeting called to approve the Initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed Initial Business Combination or conduct a tender offer will be made by the Company, solely in the Company’s discretion. The public stockholders will be entitled to redeem their shares at a per -share The shares of common stock subject to redemption was classified as temporary equity upon the completion of the Initial Public Offering and will subsequently be accreted to redemption value, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Initial Business Combination. The Company will have only 12 months from the closing of the Initial Public Offering (the “Combination Period”) to complete the Initial Business Combination. However, if we are not able to consummate the Initial Business Combination within 12 months, we will be required to extend the period of time to consummate a business combination up to two times, each by an additional three months (for a total of up to 18 months to complete an Initial Business Combination). The Sponsor and its affiliates or designees are obligated to fund the Trust Account to extend the time for the Company to complete its Initial Business Combination. If the Company is unable to complete its Initial Business Combination within such 12 -month -share payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless if the Company fails to complete its Initial Business Combination within the 12 -month COVID-19 Pandemic In March 2020, the World Health Organization characterized the outbreak of the novel strain of coronavirus, specifically identified as COVID -19 -imposed The current challenging economic climate may lead to adverse changes in cash flows, working capital levels and/or debt balances, which may also have a direct impact on the Company’s operating results and financial position in the future. The ultimate duration and magnitude of the impact and the efficacy of government interventions on the economy and the financial effect on the Company is not known at this time. The extent of such impact will depend on future developments, which are highly uncertain and not in the Company’s control, including new information which may emerge concerning the spread and severity of COVID -19 In response to COVID -19 -19 Going Concern and Management Liquidity Plans As of December 31, 2021, the Company had cash of $154,942 and working capital deficiency of approximately $381,866. The Company’s liquidity needs prior to the consummation of the Initial Public Offering had been satisfied through proceeds from notes payable and advances from related party and from the issuance of common stock. Subsequent to the consummation of the Initial Public Offering, the Company expects that it will need additional capital to satisfy its liquidity needs beyond the net proceeds from the consummation of the Initial Public Offering and the proceeds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination. Although certain of the Company’s initial stockholders, officers and directors or their affiliates have committed to loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, there is no guarantee that the Company will receive such funds. The accompanying financial statement has been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during period leading up to the Initial Business Combination. The Company cannot provide any assurance that its plans to raise capital or to consummate an Initial Business Combination will be successful. Based on the foregoing, management believes that there is a risk that the Company will not have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of the Initial Business Combination or one year from this filing. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies	NOTE 2 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying audited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such consolidated financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley -emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short -term Cash Held in Trust Account Following the closing of the Initial Public Offering on August 12, 2021, an amount of $57,339,200 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units, Additional Units and Additional Private Units were placed in the Trust Account and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a -7 -Initial Offering Costs Offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are charged against the carrying value of the ordinary shares or the statements of operations based on the relative value of the common shares and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, on August 12, 2021, offering costs in the aggregate of $973,988 were recognized (including approximately $359,900 for the fair value of the Representative’s unit purchase option), all of which was allocated to the common shares, reducing the carrying amount of such shares as of such date. Warrant Liability The Company accounts for the Private Warrants in accordance with the guidance contained in ASC 480, Distinguishing Liabilities from Equity, -measurement -Scholes The Company’s Public Warrants are accounted for and are presented as equity and measured using a Monte Carlo simulation model. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption will be presented at redemption value and as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company has made a policy election in accordance with ASC 480 -10-S99-3A -in -in -month Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by taxing authorities since inception. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short -term Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three -tier • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic earnings per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, if dilutive. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. The Statements of Operations include a presentation of income (loss) per redeemable share and income (loss) per non -redeemable -class -redeemable -redeemable The earnings per share presented in the statement of operations is based on the following: For the period from March 18, 2021 (inception) through December 31, 2021 Net Loss $ (1,127,612 ) Accretion of temporary equity to redemption value (1,733,440 ) Net loss including accretion of temporary equity to redemption value $ (2,861,052 ) Common Non-redeemable Basic and diluted net income (loss) per share: Numerator: Allocation of net loss including accretion of temporary equity $ (1,883,391 ) $ (977,661 ) Accretion of temporary equity to redemption value 1,733,440 — Allocation of net loss $ (149,951 ) $ (977,661 ) Denominator: Weighted-average shares outstanding 2,789,393 1,447,964 Basic and diluted net income (loss) per share $ (0.05 ) $ (0.68 ) In connection with the underwriters’ exercise of the over -allotment At December 31, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the periods presented. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Dec. 31, 2021
Initial Public Offering Disclosure [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3 — INITIAL PUBLIC OFFERING On August 12, 2021, the Company consummated its Initial Public Offering of 5,000,000 Units at $10.00 per Unit, generating gross proceeds of $50,000,000 and incurred offering costs of $2,223,988, consisting of $1,250,000 of underwriting fees and expenses and $973,988 of costs related to the Initial Public Offering. Additionally, the Company recorded deferred underwriting commissions of $1,500,000 (increasing up to $1,725,000 if the underwriter’s over -allotment Simultaneously with the consummation of the closing of the Initial Public Offering, the Company completed the private sale of 276,250 Private Units to its Sponsor at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $2,762,500. On August 19, 2021, the underwriters notified the Company of their intent to exercise of the over -allotment -allotment Since the underwriters did not exercise their over -allotment We intend to use substantially all of the net proceeds of the Initial Public Offering, including the funds held in the trust account, in connection with our initial business combination and to pay our expenses relating thereto, including a deferred underwriting commission payable to the underwriters in an amount equal to 3.0% of the total gross proceeds raised in the Initial Public Offering upon consummation of our initial business combination. To the extent that our capital stock is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the trust account, as well as any other net proceeds not expended, will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the funds available to us outside of the trust account were insufficient to cover such expenses. The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 4 — RELATED PARTY TRANSACTIONS Sponsor Shares On April 12, 2021, the Company’s sponsor, Abri Ventures I, LLC (the “Sponsor”) purchased 1,437,500 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. Private Units On August 12, 2021, our Sponsor purchased an aggregate of 276,250 Private Units in a private placement that closed simultaneously with the closing of Initial Public Offering. The Private Units are comprised of one share of common stock and one redeemable warrant, each exercisable to purchase one share of common stock at $11.50 per share and are otherwise identical to the public warrants in the Initial Public Offering. On August 23, 2021, simultaneously with the sale of the Additional Units, the Company consummated the sale of an additional 18,348 Additional Private Units, generating additional gross proceeds of $183,480. All of the proceeds we received from this private placement of units were added to the proceeds from the Initial Public Offering to pay for the expenses of the Initial Public Offering and to be held in the Trust Account. If we do not complete our Initial Business Combination within 12 months from the closing of this Initial Public Offering (or up to 18 months), the proceeds of the sale of the Private Units will be used to fund the redemption of our public shares (subject to the requirements of applicable law) and the Private Units and underlying warrants will be worthless. Promissory Note — Related Party On April 20, 2021, the Company entered a promissory note with its Sponsor for principal amount received of $300,000 to be used for a portion of the expenses of the Initial Public Offering. The note was non -interest Administrative and Support Services The Company entered into an administrative services agreement pursuant to which the Company will pay the Sponsor a total of $10,000 per month for office space, administrative and support services, which the Company records as operating expense on its statements of operations. Upon the completion of the Initial Business Combination or our liquidation, the Company will cease paying these monthly fees.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5 — COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares are entitled to registration rights pursuant to a registration rights agreement that was signed as of the effective date of the Initial Public Offering. The holders of the majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. In addition, the holders have certain “piggy -back -trading Initial Business Combination, we complete a liquidation, merger, stock exchange or other similar transaction which results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property. The Founder Shares will be held in escrow with Continental Stock Transfer & Trust Company during the period in which they are subject to the transfer restrictions described above. Unit Purchase Option We sold to the underwriters, for $100, an option to purchase up to a total of 300,000 units (increased to 344,035 units after the over -allotment five -up -year -day -back -back On August 12, 2021, the Company accounted for the unit purchase option, inclusive of the receipt of $100 cash payment, as an expense of the Initial Public Offering resulting in a charge directly to stockholders’ equity.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 6 — STOCKHOLDERS’ EQUITY Common Stock The Company is authorized to issue an aggregate of 5,000,000 shares of common stock having a par value of $0.0001 per share. From inception, March 18, 2021 through August 12, 2021, the Company issued 1,437,500 founder shares of common stock at a price of $0.0001 per share for total receivable of approximately of $25,000. These Founder Shares held by our Sponsor included up to 187,500 shares which were subject to forfeiture by the stockholder if the underwriters of the Company’s Initial Public Offering did not fully or in part exercise their over -allotment -allotment -allotment August 23, 2021, simultaneously with the sale of the Additional Units, the Company consummated the sale of an additional 18,348 Additional Private Units, generating additional gross proceeds of $183,480. The balance of the Additional Private Units, or 402 Private Units, including 4,020 Founder Shares, were forfeited by the Sponsor. Authorized Stock Upon the effectiveness of the Company’s registration statement on August 9, 2021, the Company amended and restated its certificate of incorporation to authorize the issuance of up to 100,000,000 shares of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. Public and Private Warrants Each whole warrant entitles the registered holder to purchase one common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of the completion of an Initial Business Combination and one year from the consummation of the Company’s Initial Public Offering. The warrants will expire five No public warrants will be exercisable for cash unless we have an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares. It is our current intention to have an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares in effect promptly following consummation of an Initial Business Combination. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within 90 days following the consummation of our Initial Business Combination, public warrant holders may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis. We may redeem the outstanding warrants, in whole and not in part, at a price of $0.01 per warrant: • • • -trading • -day If the foregoing conditions are satisfied and we issue a notice of redemption, each warrant holder can exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the shares of common stock may fall below the $16.50 trigger price as well as the $11.50 warrant exercise price per share after the redemption notice is issued and not limit our ability to complete the redemption. The redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then -prevailing If we call the warrants for redemption as described above, our management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Whether we will exercise our option to require all holders to exercise their warrants on a “cashless basis” will depend on a variety of factors including the price of our shares of common stock at the time the warrants are called for redemption, our cash needs at such time and concerns regarding dilutive share issuances. Common Stock Subject to Redemption The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. As of December 31, 2021, there were 5,733,920 shares of common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet. The common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table: Gross proceeds from Initial Public Offering $ 57,338,908 Less: Fair Value of Public Warrants at Issuance (3,201,883 ) Offering Costs allocated to common stock subject to possible redemption (3,547,176 ) Plus: Accretion of common stock subject to possible redemption amount 1,733,440 Common stock subject to possible redemption $ 52,323,289

Warrants

Warrants	9 Months Ended
	Dec. 31, 2021
Warrants [Abstract]
WARRANTS	NOTE 7 — WARRANTS On August 12, 2021, the Company consummated its Initial Public Offering of 5,000,000 Units at $10.00 per Unit, generating gross proceeds of $50,000,000, with each Unit consisting of one share of common stock, $0.0001 par value, and one redeemable warrant. The Company granted the underwriter a 45 -day -allotments Simultaneously with the consummation of the closing of the Initial Public Offering, the Company completed the private sale of 276,250 Private Units to its Sponsor at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $2,762,500, with each Private Unit consisting of one share of common stock, $0.0001 par value, and one redeemable warrant. Upon consummation of our Initial Public Offering, we sold to the underwriters, for $100, an option to purchase up to a total of 300,000 units (increased to 344,035 units after the over -allotment five -up On August 19, 2021, the underwriters notified the Company of their intent to exercise of the over -allotment -allotment Each Private Unit, Additional Unit and Additional Private Unit are identical to the Unit from our Initial Public Offering except as described below. The Sponsor has agreed to waive its redemption rights with respect to any shares underlying the Private Units (i) in connection with the consummation of a business combination, (ii) in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to allow redemption in connection with our Initial Business Combination or certain amendments to our charter prior thereto, to redeem 100% of our public shares if we do not complete our Initial Business Combination within 12 months from the completion of this offering (or up to 18 months from the closing of this offering if extended) or with respect to any other provision relating to stockholders’ rights or pre -Initial -month The Private Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of our Initial Business Combination except to permitted transferees. The Company evaluated the Public and Private Warrants as either equity -classified -classified ASC 815 -40 , Derivatives and Hedging — Contracts in Entity’s Own Equity Certain adjustments to the settlement amount of the Private warrants are based on a variable that is not an input to the fair value of an option as defined under ASC 815 — 40, and thus the warrants are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon issuance of the warrants at the closing of the Initial Public Offering. Accordingly, the Company classified each Private Warrant as a liability at its fair value, with subsequent changes in their respective fair values recognized in the statements of operations and comprehensive income (loss) at each reporting date. The Company accounts for the Public Warrants as equity based on its initial evaluation that the Public Warrants are indexed to the Company’s own stock. The fair value of the Public Warrants was approximately $0.60 per Public Warrant, which was determined by the Monte Carlo simulation model. The Public Warrants will be recorded at the amount of allocated proceeds and will not be remeasured every reporting period.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 8 — FAIR VALUE MEASUREMENTS The Company carries cash equivalents, marketable investments, Private Warrants, at fair value. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. The Company’s Cash held in Trust Account is classified within Level 1 of the fair value hierarchy. The Company’s warrant liability has been valued as Level 3 instruments. The estimated fair value of the Private Warrants is determined using Level 3 inputs. Inherent in a Black -Scholes -free -free The fair value of the Private Warrants from the private placement that closed simultaneously with the closing of the Initial Public Offering was approximately $176,759, which was determined by the Black -Scholes -free -free The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Fair value measurements at Description Fair Value Quoted Significant Significant Assets: Cash $ 154,942 $ 154,942 $ — $ — Cash held in Trust Account – U.S. Money Market $ 57,340,207 $ 57,340,207 $ — $ — Liabilities: Warrant liabilities $ 170,867 $ — $ — $ 170,867 In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Income Taxes

Income Taxes	9 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9 — INCOME TAXES The Company accounts for income taxes under ASC 740 — Income Taxes (“ASC 740”), which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. Significant components of the Company’s deferred tax assets as of December 31, 2020 are summarized below. December 31, Deferred tax assets: Net operation loss carryforwards $ 316,000 Total deferred tax asset 316,000 Valuation allowance (316,000 ) $ — The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax -planning The Company’s ability to utilize net operating loss carryforwards will depend on its ability to generate adequate future taxable income. Future utilization of the net operating loss carry forwards is subject to certain limitations under Section 382 of the Internal Revenue Code. As of December 31, 2021, the Company had net operating loss carryforwards available to offset future taxable income in the amounts of approximately $1,134,000. Federal net operating loss carryforwards generated do not expire whereas state carryforwards begin to expire in 2040. The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense. The Company is subject to franchise tax and filing requirements in the State of Delaware and has accrued approximately $78,000 for such tax liability as of December 31, 2021.

Subsequent Events

Subsequent Events	9 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 — SUBSEQUENT EVENTS Management evaluated subsequent events and transactions that occurred after the balance sheet date, up to the date that the financial statements were issued. Based upon this review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements other than the below: Merger Agreement On January 27, 2022, the Company entered into a Merger Agreement (the “Merger Agreement”) by and among Abri, Abri Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Abri (“Merger Sub”), Apifiny Group Inc., a Delaware corporation (“Apifiny”), Erez Simha solely in his capacity as representative, agent and attorney -in-fact -in-fact directors of Abri has (i) approved and declared advisable the Merger Agreement, the Merger and the other transactions contemplated thereby and (ii) resolved to recommend approval of the Merger Agreement and related transactions by the stockholders of Abri. The Merger is expected to be consummated after obtaining the required approval by the shareholders of Abri and Apifiny and the satisfaction of certain other customary closing conditions. The total consideration to be paid at Closing (the “Initial Consideration”) by Abri to Apifiny security holders will be an amount equal to $450 Million. The Initial Consideration will be payable in shares of common stock, par value $0.0001 per share, of Abri (“Abri Common Stock”) valued at $10 per share. In addition to the Initial Consideration, the Apifiny security holders (the Earnout Recipients as defined in the Merger Agreement) will also have the contingent right to earn up to 10,500,000 • -weighted • • •

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying audited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such consolidated financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley -emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and cash equivalents The Company considers all short -term
Cash Held in Trust Account	Cash Held in Trust Account Following the closing of the Initial Public Offering on August 12, 2021, an amount of $57,339,200 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units, Additional Units and Additional Private Units were placed in the Trust Account and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a -7 -Initial
Offering Costs	Offering Costs Offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are charged against the carrying value of the ordinary shares or the statements of operations based on the relative value of the common shares and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, on August 12, 2021, offering costs in the aggregate of $973,988 were recognized (including approximately $359,900 for the fair value of the Representative’s unit purchase option), all of which was allocated to the common shares, reducing the carrying amount of such shares as of such date.
Warrant Liability	Warrant Liability The Company accounts for the Private Warrants in accordance with the guidance contained in ASC 480, Distinguishing Liabilities from Equity, -measurement -Scholes The Company’s Public Warrants are accounted for and are presented as equity and measured using a Monte Carlo simulation model.
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption will be presented at redemption value and as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company has made a policy election in accordance with ASC 480 -10-S99-3A -in -in -month
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by taxing authorities since inception.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short -term
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three -tier • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Net Loss Per Share	Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic earnings per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, if dilutive. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. The Statements of Operations include a presentation of income (loss) per redeemable share and income (loss) per non -redeemable -class -redeemable -redeemable The earnings per share presented in the statement of operations is based on the following: For the period from March 18, 2021 (inception) through December 31, 2021 Net Loss $ (1,127,612 ) Accretion of temporary equity to redemption value (1,733,440 ) Net loss including accretion of temporary equity to redemption value $ (2,861,052 ) Common Non-redeemable Basic and diluted net income (loss) per share: Numerator: Allocation of net loss including accretion of temporary equity $ (1,883,391 ) $ (977,661 ) Accretion of temporary equity to redemption value 1,733,440 — Allocation of net loss $ (149,951 ) $ (977,661 ) Denominator: Weighted-average shares outstanding 2,789,393 1,447,964 Basic and diluted net income (loss) per share $ (0.05 ) $ (0.68 ) In connection with the underwriters’ exercise of the over -allotment At December 31, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the periods presented.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of condensed statement of operations	Net Loss $ (1,127,612 ) Accretion of temporary equity to redemption value (1,733,440 ) Net loss including accretion of temporary equity to redemption value $ (2,861,052 ) Common Non-redeemable Basic and diluted net income (loss) per share: Numerator: Allocation of net loss including accretion of temporary equity $ (1,883,391 ) $ (977,661 ) Accretion of temporary equity to redemption value 1,733,440 — Allocation of net loss $ (149,951 ) $ (977,661 ) Denominator: Weighted-average shares outstanding 2,789,393 1,447,964 Basic and diluted net income (loss) per share $ (0.05 ) $ (0.68 )

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of common stock subject to possible redemption reflected on the balance sheet	Gross proceeds from Initial Public Offering $ 57,338,908 Less: Fair Value of Public Warrants at Issuance (3,201,883 ) Offering Costs allocated to common stock subject to possible redemption (3,547,176 ) Plus: Accretion of common stock subject to possible redemption amount 1,733,440 Common stock subject to possible redemption $ 52,323,289

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of assets that are measured at fair value on a recurring basis	Fair value measurements at Description Fair Value Quoted Significant Significant Assets: Cash $ 154,942 $ 154,942 $ — $ — Cash held in Trust Account – U.S. Money Market $ 57,340,207 $ 57,340,207 $ — $ — Liabilities: Warrant liabilities $ 170,867 $ — $ — $ 170,867

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of significant components of the Company’s deferred tax assets	December 31, Deferred tax assets: Net operation loss carryforwards $ 316,000 Total deferred tax asset 316,000 Valuation allowance (316,000 ) $ —

Nature of the Organization an_2

Nature of the Organization and Business (Details) - USD ($)	Aug. 12, 2021	Aug. 23, 2021	Dec. 31, 2021	Dec. 31, 2021
Nature of the Organization and Business (Details) [Line Items]
Private sale units (in Shares)			276,250
Purchase price per unit (in Dollars per share)			$ 10
Generating gross proceeds		$ 183,480	$ 2,762,500	$ 57,338,908
Net proceeds		$ 7,339,200
Additional private sale units (in Shares)		18,348
Additional private per share (in Dollars per share)		$ 10
Proceeds held trust account		$ 57,339,200
Percentage of fair market value			80.00%
Percentage of outstanding voting rights			50.00%
General and administrative services			$ 10,000
Trust account public stockholders			$ 10,000
Total gross proceeds raised percentage			3.00%
Repayment expenses			$ 15,000
Warrant price per share (in Dollars per share)			$ 1
Public per share (in Dollars per share)			$ 10
Net tangible assets			$ 5,000,001	5,000,001
Cash			154,942	154,942
IPO [Member]
Nature of the Organization and Business (Details) [Line Items]
Sale of stock (in Shares)	5,000,000
Sale of price per unit (in Dollars per share)	$ 10
Gross proceeds	$ 50,000,000
Offering costs	$ 973,988
Additional shares (in Shares)	750,000
Net proceeds	$ 50,000,000
Maturity terms	185 days
Public shares redeem percentage	100.00%
Cash			381,866	$ 381,866
Over-Allotment Option [Member]
Nature of the Organization and Business (Details) [Line Items]
Generating gross proceeds		$ 7,339,200
Underwriters shares purchased (in Shares)		733,920
Additional unit per share (in Dollars per share)		$ 10
Business Combination [Member]
Nature of the Organization and Business (Details) [Line Items]
Initial business combination			$ 750,000
Initial business combination description			If the Company is unable to complete its Initial Business Combination within such 12-month period from the closing of the Initial Public Offering or during any mandatory extension period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Details) - USD ($)	Aug. 12, 2021	Apr. 19, 2021	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies (Details) [Line Items]
Aggregate offering costs	$ 973,988
Fair value of representative’s unit purchase option amount	359,900
Amount of company accretion			$ 1,733,440
Amount of company unrecognized accretion			5,015,911
Federal depository insurance coverage limit			$ 250,000
Redeemable public shares percentage			66.00%
Non-redeemable shares percentage			34.00%
Common stock warrants (in Shares)		187,500
IPO [Member]
Organization and Summary of Significant Accounting Policies (Details) [Line Items]
Sale of net proceeds	$ 57,339,200
Maturity terms	185 days
Public shares percent	100.00%

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies (Details) - Schedule of condensed statement of operations	9 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Condensed Income Statements, Captions [Line Items]
Net Loss	$ (1,127,612)
Accretion of temporary equity to redemption value	(1,733,440)
Net loss including accretion of temporary equity to redemption value	(2,861,052)
Common Shares Subject to Redemption [Member]
Numerator:
Allocation of net loss including accretion of temporary equity	(1,883,391)
Accretion of temporary equity to redemption value	1,733,440
Allocation of net loss	$ (149,951)
Denominator:
Weighted-average shares outstanding (in Shares) | shares	2,789,393
Basic and diluted net income (loss) per share (in Dollars per share) | $ / shares	$ (0.05)
Non-redeemable Common Shares [Member]
Numerator:
Allocation of net loss including accretion of temporary equity	$ (977,661)
Accretion of temporary equity to redemption value
Allocation of net loss	$ (977,661)
Denominator:
Weighted-average shares outstanding (in Shares) | shares	1,447,964
Basic and diluted net income (loss) per share (in Dollars per share) | $ / shares	$ (0.68)

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Aug. 12, 2021	Aug. 23, 2021	Dec. 31, 2021	Sep. 20, 2021
Initial Public Offering (Details) [Line Items]
Underwriting fees	$ 1,250,000
Expenses	973,988
Deferred underwriting commissions	$ 1,500,000
Private sale units (in Shares)			276,250
Purchase price per unit (in Dollars per share)			$ 10
Proceeds value of initial public offering			$ 2,762,500
Additional gross proceeds		$ 183,480
Additional private sale units (in Shares)		18,348
Net proceeds		$ 7,339,200
IPO [Member]
Initial Public Offering (Details) [Line Items]
Share issued (in Shares)	5,000,000
Stock price per share (in Dollars per share)	$ 10
Gross proceeds	$ 50,000,000
Offering costs	2,223,988
Net proceeds	50,000,000
Gross proceeds percentage			3.00%
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Deferred underwriting commissions	$ 1,725,000
Underwriters purchased (in Shares)		733,920
Additional units per share (in Dollars per share)		$ 10
Additional gross proceeds		$ 7,339,200
Over-Allotment Option [Member] | Common Stock [Member]
Initial Public Offering (Details) [Line Items]
Shares issued (in Shares)			4,020
Private Placement [Member] | IPO [Member]
Initial Public Offering (Details) [Line Items]
Net proceeds				$ 57,338,908

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Aug. 12, 2021	Apr. 12, 2021	Aug. 23, 2021	Dec. 31, 2021	Dec. 31, 2021	Apr. 20, 2021
Related Party Transactions (Details) [Line Items]
Additional private sale units (in Shares)			18,348
Generating gross proceeds			$ 183,480	$ 2,762,500	$ 57,338,908
Principal amount received						$ 300,000
Outstanding under note				0
General and administrative services				$ 10,000
IPO [Member]
Related Party Transactions (Details) [Line Items]
Common stock per share (in Dollars per share)	$ 11.5
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Purchased shares (in Shares)		1,437,500
Aggregate price		$ 25,000
Aggregate shares (in Shares)	276,250

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	9 Months Ended
	Dec. 31, 2021	Aug. 12, 2021
Commitments and Contingencies (Details) [Line Items]
Founder shares percentage	50.00%
Common stock equals or exceeds per shares (in Dollars per share)	$ 12.5
Business combination remaining percentage	50.00%
Underwriters sales (in Dollars)	$ 100
Option to purchase share	300,000
Option to purchase (in Dollars per share)	$ 11.5
Expired term	5 years
Option units	300,000
Common stock shares	300,000
Warrants purchased	300,000
Registration rights description	Notwithstanding the foregoing, the underwriters and their related persons may not (i) have more than one demand registration right at our expense, (ii) exercise their demand registration rights more than five (5) years from the effective date of the registration statement, and (iii) exercise their “piggy-back” registration rights more than seven (7) years from the effective date of the registration statement.
Cash payment (in Dollars)	$ 100	$ 100
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Exercised shares	344,035

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	Aug. 09, 2021	Aug. 23, 2021	Aug. 12, 2021	Dec. 31, 2021
Stockholders' Equity (Details) [Line Items]
Common stock, share authorized				5,000,000
Common stock, par value (in Dollars per share)				$ 0.0001
Founder shares		4,020	1,437,500
Founder shares per price (in Dollars per share)	$ 0.0001		$ 0.0001
Total receivable (in Dollars)			$ 25,000
Share subject to forfeiture				187,500
Generating gross proceeds (in Dollars)		$ 183,480
Additional private sale units		18,348
Issuance shares	100,000,000
Preferred stock	1,000,000
Preferred stock par value (in Dollars per share)	$ 0.0001
Common stock price per share (in Dollars per share)				$ 11.5
Initial business combination				1 year
Warrants expire				5 years
Description of warrants for redemption				We may redeem the outstanding warrants, in whole and not in part, at a price of $0.01 per warrant:•        at any time while the warrants are exercisable;•        upon a minimum of 30 days’ prior written notice of redemption;•        if, and only if, the last sales price of our shares of common stock equals or exceeds $16.50 per share for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption; and•        if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.
Trigger price (in Dollars per share)				$ 16.5
Warrant exercise price per share (in Dollars per share)				$ 11.5
Common Stock Subject to Redemption [M,ember]
Stockholders' Equity (Details) [Line Items]
Common stock, share authorized				100,000,000
Common stock, par value (in Dollars per share)				$ 0.0001
Common stock outstanding subject to possible redemption				5,733,920
Over-Allotment Option [Member]
Stockholders' Equity (Details) [Line Items]
Underwriters shares purchased		733,920
Additional unit per share (in Dollars per share)		$ 10
Generating gross proceeds (in Dollars)		$ 7,339,200

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of common stock subject to possible redemption reflected on the balance sheet - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Aug. 23, 2021	Dec. 31, 2021	Dec. 31, 2021
Schedule of common stock subject to possible redemption reflected on the balance sheet [Abstract]
Gross proceeds from Initial Public Offering	$ 183,480	$ 2,762,500	$ 57,338,908
Fair Value of Public Warrants at Issuance			(3,201,883)
Offering Costs allocated to common stock subject to possible redemption			(3,547,176)
Accretion of common stock subject to possible redemption amount			1,733,440
Common stock subject to possible redemption		$ 25,000	$ 52,323,289

Warrants (Details)

Warrants (Details) - USD ($)	Aug. 12, 2021	Aug. 23, 2021	Dec. 31, 2021	Dec. 31, 2021
Warrants (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Private sale units			276,250
Purchase price per unit (in Dollars per share)			$ 10
Generating gross proceeds (in Dollars)		$ 183,480	$ 2,762,500	$ 57,338,908
Underwriters sales (in Dollars)			$ 100
Option to purchase share			300,000
Warrants expire			5 years
Option units			300,000
Common stock shares			300,000
Warrants purchased			300,000
Cash payment (in Dollars)	$ 100		$ 100	$ 100
Purchase of additional units		18,348
Fair value of public warrants, per share (in Dollars per share)			$ 0.6
IPO [Member]
Warrants (Details) [Line Items]
Sale of stock	5,000,000
Sale of price per unit (in Dollars per share)	$ 10
Gross proceeds (in Dollars)	$ 50,000,000
Common stock, par value (in Dollars per share)	$ 0.0001
Additional amount	750,000
Over-Allotment Option [Member]
Warrants (Details) [Line Items]
Generating gross proceeds (in Dollars)		$ 7,339,200
Exercised shares			344,035
Price per share (in Dollars per share)			$ 11.5
Purchase of additional units		733,920
Per share price (in Dollars per share)		$ 10
Business Combination [Member]
Warrants (Details) [Line Items]
Business combination description			(i) in connection with the consummation of a business combination, (ii) in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to allow redemption in connection with our Initial Business Combination or certain amendments to our charter prior thereto, to redeem 100% of our public shares if we do not complete our Initial Business Combination within 12 months from the completion of this offering (or up to 18 months from the closing of this offering if extended) or with respect to any other provision relating to stockholders’ rights or pre-Initial Business Combination activity and (iii) if we fail to consummate a business combination within 12 months from the completion of this offering (or up to 18 months from the closing of this offering if extended) or if we liquidate prior to the expiration of the 18 month period. However, the Sponsor will be entitled to redemption rights with respect to any public shares it holds if we fail to consummate a business combination or liquidate within the 18-month period.

Fair Value Measurements (Detail

Fair Value Measurements (Details)	9 Months Ended
	Dec. 31, 2021USD ($)$ / shares
Fair Value Measurements (Details) [Line Items]
Initial public offering (in Dollars)	$ 176,759
Dividend yield	0.00%
Term (in years)	4 years 6 months
Volatility	11.80%
Risk-free rate	1.19%
Amount of fair value (in Dollars)	$ 170,867
Fair value of warrant liability (in Dollars)	$ 5,892
Private Placement [Member]
Fair Value Measurements (Details) [Line Items]
Exercise price (in Dollars per share) | $ / shares	$ 11.5
Black-Scholes Pricing Model [Member]
Fair Value Measurements (Details) [Line Items]
Dividend yield	0.00%
Term (in years)	5 years
Volatility	13.50%
Exercise price (in Dollars per share) | $ / shares	$ 11.5
Risk-free rate	0.81%

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis	9 Months Ended
	Dec. 31, 2021USD ($)
Assets:
Cash	$ 57,340,207
Liabilities:
Warrant liabilities	170,867
Cash and Cash Equivalents [Member]
Assets:
Cash	154,942
Quoted prices in active markets for identical liabilities (Level 1) [Member]
Assets:
Cash	57,340,207
Liabilities:
Warrant liabilities
Quoted prices in active markets for identical liabilities (Level 1) [Member] | Cash and Cash Equivalents [Member]
Assets:
Cash	154,942
Significant other observable inputs (Level 2) [Member]
Assets:
Cash
Liabilities:
Warrant liabilities
Significant other observable inputs (Level 2) [Member] | Cash and Cash Equivalents [Member]
Assets:
Cash
Significant unobservable inputs (Level 3) [Member]
Assets:
Cash
Liabilities:
Warrant liabilities	170,867
Significant unobservable inputs (Level 3) [Member] | Cash and Cash Equivalents [Member]
Assets:
Cash

Income Taxes (Details)

Income Taxes (Details)	9 Months Ended
	Dec. 31, 2021USD ($)
Income Tax Disclosure [Abstract]
Valuation allowance	$ 316,000
Taxable income	1,134,000
Tax Liability	$ 78,000

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of significant components of the company’s deferred tax assets	Dec. 31, 2021USD ($)
Deferred tax assets:
Net operation loss carryforwards	$ 316,000
Total deferred tax asset	316,000
Valuation allowance	(316,000)
Total

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions	9 Months Ended
	Dec. 31, 2021	Aug. 23, 2021
Subsequent Events (Details) [Line Items]
Total consideration (in Dollars)	$ 450
Common stock value at per share	$ 0.0001	$ 0.0001
Earnout payments, description	In addition to the Initial Consideration, the Apifiny security holders (the Earnout Recipients as defined in the Merger Agreement) will also have the contingent right to earn up to 10,500,000 shares of Abri Common Stock in the aggregate (“Earnout Consideration”) as follows:•        The Apifiny security holders will earn 3,000,000 shares of the Earnout Consideration, in the aggregate, if over any twenty (20) consecutive Trading Days (as defined in the Merger Agreement) during the period beginning on the date of the Closing (the “Closing Date”) and ending on the first anniversary of the Closing Date (the “First Earnout Period”), the volume-weighted average price (“VWAP”) (as defined in the Merger Agreement) of the Abri Common Stock is greater than or equal to $16.50 per share (the “First Milestone”).•        The Apifiny security holders will earn an additional 3,750,000 shares of the Earnout Consideration, in the aggregate, if over any twenty (20) consecutive Trading Days during the period beginning on the Closing Date and ending on the second anniversary of the Closing Date (the “Second Earnout Period”), the VWAP of the Abri Common Stock is greater than or equal to $23.00 per share (the “Second Milestone”).•        The Apifiny security holders will earn an additional 3,750,000 shares of the Earnout Consideration, in the aggregate, if within any twenty (20) consecutive Trading Day during the period beginning on the Closing Date and ending on the third anniversary of the Closing Date (the “Third Earnout Period” and together with the First Earnout Period and the Second Earnout Period, each, an “Earnout Period” and collectively, the “Earnout Periods”), the VWAP of the Abri Common Stock is greater than or equal to $30.00 per share(the “Third Milestone” and together with the First Milestone and the Second Milestone, the “Earnout Milestones”).•        Upon the first Change in Control to occur during the applicable Earnout Period, if the corresponding price per share of Abri Common Stock in connection with such Change in Control is equal to or greater than any applicable Earnout Milestone or Milestones, the Apifiny security holders will earn the shares of the Earnout Consideration issuable in respect to such Earnout Milestone or Milestones as described above as of immediately prior to the Change of Control.
Class A Common Stock [Member]
Subsequent Events (Details) [Line Items]
Common stock, par value	$ 0.0001
Common stock value at per share	$ 10